PPHM Alerts 08/24/2014 21:21:08 $PPHM
Biopharm, Your Dots May Soon CONNECT! GltaRealStockholders!
Quote:
Those "eyes" are fully aware that opportunity to load up at present low s/p will NOT be available for much longer.
Many have been waiting for the coming weeks for years and it seems like that time is here.
More interesting, is that the "PARTNERSHIPS" tab is Bayer... meant bare! ...and has been fully removed from the Peregrine website and Avid Bioservices website. There have been many website changes over the past year and now, the most recent one being the partnerships tab being removed would seem like the most logical last change before a partnership that could move Peregrine much closer to a BP in its own realm.
Hopefully it all means a new partner Soon
PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/
I like to observe that it takes confidence and not a little bit of courage to come out for a specific event like Kyoto and make a prediction or two. I don't see that coming from many others, including myself. And how easy it is to dismiss such courage as flippant and shallow. Thank you Cloaked for standing up, in black and white, for what you believe in.
To be clear...the only posts I found silly were those of the reverse split nature. Except haywards post which spelled out why a RS is usually employed which was the reason for PPHM RS. NASDAQ COMPLIANCE.
NOW.....enjoy the rest of of your Sunday....or Monday Morning for our European friends!
wook
Regardless of some silly posts which of course I wasn't part of (eh?),
we can clearly observe that over this Saturday and Sunday there was an incredible increase of traffic on this thread.
IMHO plenty of "new eyes" are focusing our way based on some EXPECTATION which attracted them to do some more searching before jumping on our bandwagon.
Those "eyes" are fully aware that opportunity to load up at present low s/p will NOT be available for much longer.
Enough said.
Krak
CP, sorry, I have to do this.
In about 10 days?
Is that soon?
Patently Amazing Paul!!!! Perfect post!!!!
wook
Krakonos, one thing is for sure, Dr. Yopp doesn't get in the Kyoto brochure, and as most mentioned, for nothing.
He seem related to one or two presentations. Not as PPHM.
So based on this argumentation I say that in case there wouldn't be Liver Results we may even get something better.
Why would he disclose being a paid consultant for Bayer/Onyx (because that he worked with UTSW and PPHM we knew) if there is no relevance.
The 5 to 7th September 2014 we'll know. That is in about 10 days.
I hope that those of you here who are from the Bay and Napa area are safe after today's rumble.
http://www.mercurynews.com
Don't need a booth to release data.
ITMN just got bought out for $8.3 billion! Let's get this done PPHM.
While I am positive about the data Dr. Yopp will eventually release on the liver IST, one things is very clear - PPHM will not have any presence at ILCA 2014 in KYOTO. NO presentations, NO posters, NO booth. Will NOT be a part of the Bayer Symposium - that is clear from the Symposium Brochure that CP posted.
IMO we hear more about the breast IST before we hear about the liver as far as data goes. Partnership wise, I foresee Liver partnership with BAYER (by default ; there is no other choice!!!) before breast (will pursue on our own). JMO
Isn't it amazing that Peregrine management got FDA approval for the Sunrise trial despite third party negligence in the related Phase II trial.
Isn't it amazing the same management achieved FDA fast-track status for Bavituximab
Isn't it amazing the same management has launched the world-wide Sunrise trial at remarkable speed.
And yes, isn't it amazing the same management managed to sell preferred stock to finance the Sunrise trial at minimal dilution to shareholder.
I always respect other points of view, but doen't the above represent a compelling basis to expect good things in Peregrine's future?
I do not mean to say Peregrine management has much talent in promoting the company or works very hard to please its shareholders with as much information as we'd like and probably deserve. I just feel their performance in pushing Bavi in the Sunrise trial is critically important to the ultimate success of the company and benefit of shareholders.
GLTA, Paul
I know Hayward....I appreciated the post. Sorry, for the misunderstanding.(my words don't always translate properly) I was going to post what you stated but was hoping to hear it from someone else. You made my day. : )
wook
#1. #2 has me giddy krak.
wook
asmarterwookie
That was in reference to why we would NOT have to do one !!! SHEESH !!!
Michael
IMO pretty clear Yopp has great data. Maybe he releases in Kyoto, maybe not. Either way, more convinced than ever that PPHM has the goods. Going to be an incredibly fun run as I see it.
Wookie, what are you talking about?
It was just "or not".
Quote:
The silliness on the board today is unprecedented.
1. The proxy issuance containing or not containing a reverse split.
2. Kyoto comes with either liver data or no liver data.
Biopharm, Your Dots May Soon CONNECT! GltaRealStockholders!
Quote:
Those "eyes" are fully aware that opportunity to load up at present low s/p will NOT be available for much longer.
Many have been waiting for the coming weeks for years and it seems like that time is here.
More interesting, is that the "PARTNERSHIPS" tab is Bayer... meant bare! ...and has been fully removed from the Peregrine website and Avid Bioservices website. There have been many website changes over the past year and now, the most recent one being the partnerships tab being removed would seem like the most logical last change before a partnership that could move Peregrine much closer to a BP in its own realm.
Hopefully it all means a new partner Soon
PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/
I like to observe that it takes confidence and not a little bit of courage to come out for a specific event like Kyoto and make a prediction or two. I don't see that coming from many others, including myself. And how easy it is to dismiss such courage as flippant and shallow. Thank you Cloaked for standing up, in black and white, for what you believe in.
To be clear...the only posts I found silly were those of the reverse split nature. Except haywards post which spelled out why a RS is usually employed which was the reason for PPHM RS. NASDAQ COMPLIANCE.
NOW.....enjoy the rest of of your Sunday....or Monday Morning for our European friends!
wook
Regardless of some silly posts which of course I wasn't part of (eh?),
we can clearly observe that over this Saturday and Sunday there was an incredible increase of traffic on this thread.
IMHO plenty of "new eyes" are focusing our way based on some EXPECTATION which attracted them to do some more searching before jumping on our bandwagon.
Those "eyes" are fully aware that opportunity to load up at present low s/p will NOT be available for much longer.
Enough said.
Krak
CP, sorry, I have to do this.
In about 10 days?
Is that soon?
Patently Amazing Paul!!!! Perfect post!!!!
wook
Krakonos, one thing is for sure, Dr. Yopp doesn't get in the Kyoto brochure, and as most mentioned, for nothing.
He seem related to one or two presentations. Not as PPHM.
So based on this argumentation I say that in case there wouldn't be Liver Results we may even get something better.
Why would he disclose being a paid consultant for Bayer/Onyx (because that he worked with UTSW and PPHM we knew) if there is no relevance.
The 5 to 7th September 2014 we'll know. That is in about 10 days.
I hope that those of you here who are from the Bay and Napa area are safe after today's rumble.
http://www.mercurynews.com
Don't need a booth to release data.
ITMN just got bought out for $8.3 billion! Let's get this done PPHM.
While I am positive about the data Dr. Yopp will eventually release on the liver IST, one things is very clear - PPHM will not have any presence at ILCA 2014 in KYOTO. NO presentations, NO posters, NO booth. Will NOT be a part of the Bayer Symposium - that is clear from the Symposium Brochure that CP posted.
IMO we hear more about the breast IST before we hear about the liver as far as data goes. Partnership wise, I foresee Liver partnership with BAYER (by default ; there is no other choice!!!) before breast (will pursue on our own). JMO
Isn't it amazing that Peregrine management got FDA approval for the Sunrise trial despite third party negligence in the related Phase II trial.
Isn't it amazing the same management achieved FDA fast-track status for Bavituximab
Isn't it amazing the same management has launched the world-wide Sunrise trial at remarkable speed.
And yes, isn't it amazing the same management managed to sell preferred stock to finance the Sunrise trial at minimal dilution to shareholder.
I always respect other points of view, but doen't the above represent a compelling basis to expect good things in Peregrine's future?
I do not mean to say Peregrine management has much talent in promoting the company or works very hard to please its shareholders with as much information as we'd like and probably deserve. I just feel their performance in pushing Bavi in the Sunrise trial is critically important to the ultimate success of the company and benefit of shareholders.
GLTA, Paul
I know Hayward....I appreciated the post. Sorry, for the misunderstanding.(my words don't always translate properly) I was going to post what you stated but was hoping to hear it from someone else. You made my day. : )
wook
#1. #2 has me giddy krak.
wook
asmarterwookie
That was in reference to why we would NOT have to do one !!! SHEESH !!!
Michael
IMO pretty clear Yopp has great data. Maybe he releases in Kyoto, maybe not. Either way, more convinced than ever that PPHM has the goods. Going to be an incredibly fun run as I see it.
Wookie, what are you talking about?
It was just "or not".
Quote:
The silliness on the board today is unprecedented.
1. The proxy issuance containing or not containing a reverse split.
2. Kyoto comes with either liver data or no liver data.
